THE FOREFRONT MOVIEBOX

NOW STREAMING NOLLYWOOD MOVIE LOVE AND FAME. AVAILABLE TILL 1200WAT ON WEDNESDAY. SIMULTANEOUSLY FURTHER DOWN THE SITE IS HOLLYWOOD ACTION MOVIE: DETECTIVE.

LIVE COVID-19 GLOBAL CASES AND DEATHS INFOGRAPHICS BY RIGHT AND LEFT BAR.

HOMEOFLAFTA RETURNS WITH ANOTHER DEBUT TOO!!! WATCH SHORT NOLLYWOOD COMEDY AT THE SITE'S BOTTOM. GO NOW.

Thursday, 18 June 2020

WHO endorses dexamethasone for treating chronic COVID-19 cases


The World Health Organisation (WHO), yesterday endorsed dexamethasone as ‘cure’ drug for saving lives of critically ill coronavirus disease (COVID-19) patients. 

Dexamethasone is a breakthrough in the global race to discover a safe and effective drug for treatment and prevention of the disease.
The WHO welcomed the initial clinical trial results from the United Kingdom (UK) that showed dexamethasone, a corticosteroid, can be life-saving for patients who are critically ill with COVID-19.
According to preliminary findings shared with WHO, for patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth. The benefit was only seen in patients seriously ill with COVID-19 and was not observed in patients with milder disease.
WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, said: “This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support.
“This is great news and I congratulate the government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this life-saving scientific breakthrough.”
Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers. It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries.
The global health body, in a statement, yesterday, said: “The researchers shared initial insights about the results of the trial with WHO, and we are looking forward to the full data analysis in the coming days. WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19.”

Receive news alert via Whatsapp from The Forefront Media Org, send a message to +2348124620827.





LIKE US ON FACEBOOK

THE FOREFRONT MEDIA ORG FACEBOOK PAGE (FOR VIDEOS, TWEETS AND MORE).


SHARE THIS POST NOW WITH OTHERS ON SOCIAL MEDIA.

No comments:

Post a comment

Disclaimer!!! Opinions expressed in comments do not represent THE FOREFRONT MEDIA ORG's views. All participants are entitled to their opinions. Thank you!!!


Advertise on the Forefront: For advert placement in the blog or advert posts like news updates, reach +2348124620827 [WhatsApp].

Copyright 2020 The Forefront Media Org. All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from The Forefront Media Org